Search Results - Ademi, Z.

Refine Results
  1. 1
    COST-UTILITY ANALYSIS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-BASED TREATMENT COMPARED TO THIAZIDE DIURETIC-BASED TREATMENT IN AN ELDERLY HYPERTENSIVE POPULATION CONSIDERING MAJOR COMORBIDITIES AT THE COMMUNITY LEVEL

    COST-UTILITY ANALYSIS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-BASED TREATMENT COMPARED TO THIAZIDE DIURETIC-BASED TREATMENT IN AN ELDERLY HYPERTENSIVE POPULATION CONSIDERING MAJ... by Chowdhury, E., Ademi, Z., Krum, H., Wing, L., Reid, Christopher

    Published 2014
    Get full text
  2. 2
    Cost-effectiveness of angiotensin-converting enzyme inhibitor-based compared to thiazide diuretic-based treatment in an elderly hypertensive population considering diabetes as a major comorbidity

    Cost-effectiveness of angiotensin-converting enzyme inhibitor-based compared to thiazide diuretic-based treatment in an elderly hypertensive population considering diabetes as a ma... by Chowdhury, E., Ademi, Z., Moss, J., Wing, L., Reid, Christopher

    Published 2015
    Get full text
  3. 3
    Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity

    Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes... by Chowdhury, E., Ademi, Z., Moss, J., Wing, L., Reid, Christopher

    Published 2015
    Get full text
    Get full text
  4. 4
    Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity

    Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity by Chowdhury, E., Ademi, Z., Moss, J., Wing, L., Reid, Christopher

    Published 2015
    Get full text
  5. 5
    A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era

    A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era by Ariyaratne, T., Yap, C., Ademi, Z., Rosenfeldt, F., Duffy, S., Billah, B., Reid, Christopher

    Published 2016
    Get full text
  6. 6
    Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort

    Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort by Ademi, Z., Liew, D., Hollingsworth, B., Steg, P., Bhatt, D., Reid, Christopher

    Published 2013
    Get full text
  7. 7
    Overview of pharmacoeconomic modelling methods

    Overview of pharmacoeconomic modelling methods by Ademi, Z., Kim, H., Zomer, E., Reid, Christopher, Hollingsworth, B., Liew, D.

    Published 2013
    Get full text
  8. 8
    Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis

    Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis by Zomer, E., Owen, A., Magliano, D., Ademi, Z., Reid, Christopher, Liew, D.

    Published 2013
    Get full text
  9. 9
    Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms

    Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms by Zomer, E., Liew, D., Owen, A., Magliano, D., Ademi, Z., Reid, Christopher

    Published 2014
    Get full text
  10. 10
    DEVELOPMENT OF A CARDIOVASCULAR MORTALITY RISK PREDICTION MODEL FOR PARTICIPANTS IN THE OHASAMA STUDY

    DEVELOPMENT OF A CARDIOVASCULAR MORTALITY RISK PREDICTION MODEL FOR PARTICIPANTS IN THE OHASAMA STUDY by Huq, M., Head, G., Owen, A., Ademi, Z., Ohkubo, T., Imai, Y., Reid, Christopher

    Published 2014
    Get full text
  11. 11
    PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS

    PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS by Ariyaratne, T., Ademi, Z., Yap, C., Billah, B., Rosenfeldt, F., Yan, B., Reid, Christopher

    Published 2012
    Get full text
  12. 12
    Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis

    Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis by Ariyaratne, T., Ademi, Z., Yap, C., Billah, B., Rosenfeldt, F., Yan, B., Reid, Christopher

    Published 2014
    Get full text
  13. 13
    Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations

    Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations by Watts, G., Juniper, A., Van Bockxmeer, F., Ademi, Z., Liew, D., O'Leary, Peter

    Published 2012
    Get full text
  14. 14
    Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective

    Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective by Zomer, E., Si, S., Hird, T., Liew, D., Owen, A., Tonkin, A., Reid, Christopher, Ademi, Z.

    Published 2018
    Get full text
  15. 15
    The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-Year follow-up data from the australian REACH registry

    The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-Year follow-up data from the australian REACH registry by Ademi, Z., Huq, M., Liew, D., Steg, P., Bhatt, D., Nelson, M., Reid, Christopher

    Published 2013
    Get full text
  16. 16
    Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients

    Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients by Chowdhury, E., Langham, R., Ademi, Z., Owen, A., Krum, H., Wing, L., Nelson, M., Reid, Christopher

    Published 2015
    Get full text
    Get full text
  17. 17
    Outcomes and excess costs among patients with cardiovascular disease

    Outcomes and excess costs among patients with cardiovascular disease by Ademi, Z., Liew, D., Zomer, E., Gorelik, A., Hollingsworth, B., Steg, P., Bhatt, D., Reid, Christopher

    Published 2013
    Get full text
  18. 18
    Short-and long-term survival in treated elderly hypertensive patients with or without diabetes: Findings from the second Australian national blood pressure study

    Short-and long-term survival in treated elderly hypertensive patients with or without diabetes: Findings from the second Australian national blood pressure study by Chowdhury, E., Owen, A., Ademi, Z., Krum, H., Johnston, C., Wing, L., Nelson, M., Reid, Christopher

    Published 2014
    Get full text
  19. 19
    Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry

    Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry by Ademi, Z., Reid, Christopher, Hollingsworth, B., Stoelwinder, J., Steg, P., Bhatt, D., Vale, M., Liew, D.

    Published 2011
    Get full text
  20. 20
    Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study

    Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study by Si, Si, Golledge, J., Norman, P., Nelson, M., Chew, D., Ademi, Z., Bhatt, D., Steg, G., Reid, Christopher

    Published 2018
    Get full text

Search Tools: